AMGN241213P320000
- 37.75
- 0.000.00%
Amgen Newsroom
Weekly Buzz: Tech stocks hit high scores on ominous day
Dow's 112-Point Fall Led By Losses In NVIDIA Corp., Amgen Shares
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Express News | "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
Market Mixed on Friday the 13th | Livestock
Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.
Thursday Ends in Index Declines | Wall Street Today
Unpacking the Latest Options Trading Trends in Amgen
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Why Amgen Inc. (AMGN) Is the Best Safe Stock to Buy According to Analysts?
Amgen To Go Ex-Dividend On February 14th, 2025 With 2.38 USD Dividend Per Share
10 Health Care Stocks Whale Activity In Today's Session
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Oppenheimer Remains a Buy on Amgen (AMGN)
BofA Restarts Coverage of 11 Large-cap Biopharmas
Amgen Boosts Quarterly Dividend by Nearly 6%
Amgen Raises Qtr Dividend to $2.38 Vs. $2.25 >AMGN
Express News | Amgen Announces 2025 First Quarter Dividend
Unusual Options Activity: AI, MSTR and Others Attract Market Bets, AI V/OI Ratio Reaches 249.3